Satsuki Matsunaga
Kitakyushu, 8078555, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Effectiveness of biological disease-modifying antirheumatic drugs in progressive pulmonary fibrosis associated with rheumatoid arthritis.
Journal: Rheumatology (Oxford, England)
Published: February 08, 2026
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a long-term multicenter observational study.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 06, 2025
Effective Second-Line b/tsDMARDs for Patients with Rheumatoid Arthritis Unresponsive to First-Line b/tsDMARDs from the FIRST Registry.
Journal: Rheumatology and therapy
Published: November 22, 2024
Efficacy and Safety of Biologics in Polymyalgia Rheumatica: A Retrospective Study.
Journal: Rheumatology and therapy
Published: April 07, 2024
Efficacy, safety and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry.
Journal: Rheumatology (Oxford, England)
Published: April 02, 2024
Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry.
Journal: Rheumatology and therapy
Published: August 17, 2023
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study.
Journal: Rheumatology (Oxford, England)
Published: June 12, 2023
A case of glucocorticoid-resistant adult Still's disease complicated by pulmonary hypertension and interstitial lung disease.
Journal: Modern rheumatology case reports
Published: May 06, 2022
A case of mixed connective tissue disease complicated by pulmonary hypertension and ascites after addition of pulmonary vasodilators.
Journal: Modern rheumatology case reports
Published: August 10, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026